Evidence map›Paper›PMID 34946871›Full record

ArticleGenes2021

Identification and Characterization of a Novel Recurrent

Khouloud Zayoud, Ichraf Kraoua, Asma Chikhaoui, Nadège Calmels, Sami Bouchoucha, Cathy Obringer, Clément Crochemore, Dorra Najjar, Sinda Zarrouk, Najoua Miladi and 4 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Khouloud ZayoudLaboratory of Biomedical Genomics and Oncogenetics (LR16IPT05), Institut Pasteur de Tunis, Université Tunis El Manar, El Manar I, Tunis 1002, Tunisia.
Ichraf KraouaLR18SP04 and Department of Child and Adolescent Neurology, National Institute Mongi Ben Hmida of Neurology, Tunis 1007, Tunisia.
Asma ChikhaouiLaboratory of Biomedical Genomics and Oncogenetics (LR16IPT05), Institut Pasteur de Tunis, Université Tunis El Manar, El Manar I, Tunis 1002, Tunisia.
Nadège CalmelsLaboratoires de Diagnostic Génétique, Institut de Génétique Médicale d'Alsace, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
Sami BouchouchaService Orthopédie, Hôpital d'enfant Béchir Hamza, Tunis 1000, Tunisia.
Cathy ObringerLaboratoire de Génétique Médicale, INSERM U1112, Institut de génétique médicale d'Alsace, CRBS, 67000 Strasbourg, France.
Clément CrochemoreInstitut Pasteur, Team Stability of Nuclear and Mitochondrial DNA, Stem Cells and Development, UMR 3738 CNRS, 25-28 rue du Dr. Roux, 75015 Paris, France.
Dorra NajjarLaboratory of Biomedical Genomics and Oncogenetics (LR16IPT05), Institut Pasteur de Tunis, Université Tunis El Manar, El Manar I, Tunis 1002, Tunisia.
Sinda ZarroukGenomics Platform, Institut Pasteur de Tunis (IPT), Tunis-Belvédère, Tunis 1002, Tunisia.
Najoua MiladiMaghreb Medical Center, El Manar III, Tunis 9000, Tunisia.
Vincent LaugelLaboratoire de Génétique Médicale, INSERM U1112, Institut de génétique médicale d'Alsace, CRBS, 67000 Strasbourg, France.
Miria RicchettiInstitut Pasteur, Team Stability of Nuclear and Mitochondrial DNA, Stem Cells and Development, UMR 3738 CNRS, 25-28 rue du Dr. Roux, 75015 Paris, France.
Ilhem TurkiLR18SP04 and Department of Child and Adolescent Neurology, National Institute Mongi Ben Hmida of Neurology, Tunis 1007, Tunisia.
Houda Yacoub-YoussefLaboratory of Biomedical Genomics and Oncogenetics (LR16IPT05), Institut Pasteur de Tunis, Université Tunis El Manar, El Manar I, Tunis 1002, Tunisia.ORCID 0000-0001-5351-4775
Institut Pasteur de Tunis · TNInserm · FRCentre National de la Recherche Scientifique · FRNational Institute of Neurology Mongi-Ben Hamida · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cockayne syndrome (CS) is a rare disease caused by mutations in

Indexed as

MutationBlotting, WesternCells, CulturedChildChild, PreschoolCockayne SyndromeConsanguinityDNA HelicasesDNA RepairDNA Repair EnzymesFemaleFibroblastsHomozygoteHumansMagnetic Resonance ImagingMaleDNA HelicasesDNA Repair EnzymesERCC6 protein, humanPoly-ADP-Ribose Binding Proteinsaccelerated agingCockayne syndromeDNA repair disorderERCC6neurodegeneration

Identifiers

PMID34946871
PMCPMC8701866
OpenAlexW3216597268

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.